INKT (STOCKS)
MiNK Therapeutics, Inc. Common Stock
$11.950000
+0.910000 (+8.24%)
Prev close: $11.040000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jennifer S. Buell
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $58.05M
- Employees
- 23
- P/E (TTM)
- -3.90
- P/B (TTM)
- -3.82
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $180.25K |
| Benefits Costs and Expenses | $12.67M |
| Costs And Expenses | $12.67M |
| Operating Expenses | $12.82M |
| Research and Development | $5.76M |
| Other Operating Expenses | $7.06M |
| Operating Income/Loss | -$12.64M |
| Income/Loss From Continuing Operations After Tax | -$12.49M |
| Income/Loss From Continuing Operations Before Tax | -$12.49M |
| Interest And Dividend Income, Operating | $70.25K |
| Interest Expense, Operating | -$110.00K |
| Interest Income/Expense After Provision For Losses | $180.25K |
| Interest Income/Expense Operating, Net | $180.25K |
| Net Income/Loss | -$12.49M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$12.49M |
| Net Income/Loss Available To Common Stockholders, Basic | -$12.49M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$2.93 |
| Diluted Earnings Per Share | -$2.93 |
| Basic Average Shares | 4,270,470 |
| Diluted Average Shares | 4,270,470 |
| Assets | $14.24M |
| Current Assets | $13.85M |
| Prepaid Expenses | $276.43K |
| Other Current Assets | $13.57M |
| Noncurrent Assets | $390.87K |
| Fixed Assets | $390.87K |
| Liabilities | $28.47M |
| Current Liabilities | $13.03M |
| Accounts Payable | $3.43M |
| Other Current Liabilities | $9.61M |
| Noncurrent Liabilities | $15.44M |
| Equity | -$14.23M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$14.23M |
| Liabilities And Equity | $14.24M |
| Net Cash Flow From Operating Activities | -$5.93M |
| Net Cash Flow From Operating Activities, Continuing | -$5.93M |
| Net Cash Flow From Investing Activities | -$8.78M |
| Net Cash Flow From Investing Activities, Continuing | -$8.80M |
| Net Cash Flow From Financing Activities | $14.72M |
| Net Cash Flow From Financing Activities, Continuing | $14.72M |
| Exchange Gains/Losses | -$13.43K |
| Net Cash Flow | $13.43K |
| Net Cash Flow, Continuing | $26.86K |
| Comprehensive Income/Loss | -$12.58M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$12.58M |
| Other Comprehensive Income/Loss | -$87.34K |